Cryo-Cell net income rises to $555,000 in FY26 Q2; revenue slips 2% to $7.8 million
CCEL•Cryo-Cell reports higher net income despite lower revenue
Cryo-Cell posted fiscal Q2 2026 revenue of $7.8 million, down 2% from the year-earlier quarter.
Net income rose to $555,000, or $0.07 per share, from $356,000, or $0.04 per share.
Processing and storage fee revenue slipped to $7.71 million; public banking revenue increased to $46,000.
Product revenue was flat at $14,000, while the quarter’s revenue decline was driven by lower processing and storage fees.
